Agalimmune Ltd, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours.
Agalimmune established to develop innovative immunotherapeutics for treatment of cancer
Tuesday, November 26, 2013
Agalimmune established to develop innovative immunotherapeutics for treatment of cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment